Kalaris Therapeutics logo

Kalaris Therapeutics

KLRS | NASDAQ
Chart Builder DCF Calculator
$1.46
-$0.11 (-7.30%)
At close: Nov 16, 2026, 4:00 PM ET
$1.46
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-7.30%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
34.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #679/1021 (Top 67%)

Key Statistics

Market Data

Market Cap $34.76M
1D Range
1.41 1.65
52W Range
1.41 10.98

Valuation (TTM)

PE -0.79
PB 0.73
EV/EBITDA 1.04

Valuation (NTM)

Forward PE N/A
Forward PEG 0.02
Price Target $18.00
Loading financial charts...

Profile

Kalaris Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for prevalent retinal diseases. It develops TH103, a clinical-sta...

Sector Healthcare
Industry Biotechnology
Employees 20
IPO Date Jul 30, 2020
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$18.00
Upside
+1132.88%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.